IRIS - Res&Arch Institutional Research Information System - Research & Archive

CAMILLONI, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.961
AS - Asia 3.302
EU - Europa 2.738
SA - Sud America 556
AF - Africa 71
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.640
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.843
SG - Singapore 1.473
IE - Irlanda 523
VN - Vietnam 467
HK - Hong Kong 455
UA - Ucraina 437
BR - Brasile 436
CN - Cina 411
RU - Federazione Russa 402
IT - Italia 339
DE - Germania 251
FR - Francia 185
FI - Finlandia 183
KR - Corea 120
SE - Svezia 117
GB - Regno Unito 99
IN - India 75
CA - Canada 58
TR - Turchia 55
BD - Bangladesh 45
AR - Argentina 39
MX - Messico 39
AT - Austria 33
PK - Pakistan 27
PL - Polonia 27
BE - Belgio 23
NL - Olanda 23
EC - Ecuador 22
IQ - Iraq 21
ID - Indonesia 20
CH - Svizzera 19
SA - Arabia Saudita 19
JP - Giappone 17
UZ - Uzbekistan 16
ZA - Sudafrica 15
CO - Colombia 14
ES - Italia 13
LB - Libano 13
MA - Marocco 13
PH - Filippine 13
PT - Portogallo 13
CZ - Repubblica Ceca 11
VE - Venezuela 11
CL - Cile 10
PY - Paraguay 10
LT - Lituania 9
GR - Grecia 7
AU - Australia 6
AZ - Azerbaigian 6
KE - Kenya 6
MY - Malesia 6
OM - Oman 6
TN - Tunisia 6
BG - Bulgaria 5
BO - Bolivia 5
EG - Egitto 5
JO - Giordania 5
PE - Perù 5
RO - Romania 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
GH - Ghana 4
IL - Israele 4
NP - Nepal 4
TH - Thailandia 4
EU - Europa 3
PS - Palestinian Territory 3
RS - Serbia 3
UY - Uruguay 3
AL - Albania 2
AO - Angola 2
BH - Bahrain 2
BY - Bielorussia 2
CG - Congo 2
CI - Costa d'Avorio 2
ET - Etiopia 2
KH - Cambogia 2
NZ - Nuova Zelanda 2
PA - Panama 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AM - Armenia 1
BB - Barbados 1
BN - Brunei Darussalam 1
CU - Cuba 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GF - Guiana Francese 1
GN - Guinea 1
GP - Guadalupe 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 10.617
Salva come PNG Salva come JPEG
Città #
Singapore 1.093
Chandler 541
Dublin 522
Hong Kong 454
San Jose 393
Dong Ket 290
Ashburn 283
San Mateo 240
Jacksonville 238
Boardman 166
Moscow 158
Santa Clara 155
Lauterbourg 124
Medford 115
Princeton 115
Munich 108
Beijing 105
Seoul 104
Perugia 101
Wilmington 82
Ho Chi Minh City 74
Andover 73
Ann Arbor 72
Los Angeles 62
Helsinki 56
New York 54
São Paulo 45
Altamura 38
Piscataway 36
Izmir 33
Lawrence 32
Orem 32
Turku 31
Columbus 30
The Dalles 29
Saint Petersburg 28
Hanoi 26
Des Moines 25
Rome 25
Genoa 23
London 23
Brooklyn 21
Falls Church 21
Norwalk 21
Nuremberg 21
Ottawa 20
Vienna 19
Frankfurt am Main 18
Redwood City 18
Warsaw 18
Houston 17
Redmond 17
Chennai 16
Montreal 16
Amsterdam 15
Boston 14
Dongjak-gu 14
Tokyo 14
Brussels 13
Denver 13
Mexico City 13
Dallas 12
Johannesburg 12
Chicago 11
Hefei 11
Mumbai 11
Rio de Janeiro 11
Florence 10
Stockholm 10
Terni 10
Ankara 9
Belo Horizonte 9
Curitiba 9
Da Nang 9
Manchester 9
Shanghai 9
Toronto 9
Woodbridge 9
Council Bluffs 8
Haiphong 8
Jakarta 8
San Francisco 8
Seattle 8
Atlanta 7
Baghdad 7
Falconara Marittima 7
Guarulhos 7
Karachi 7
Milan 7
Porto 7
Porto Alegre 7
Baku 6
Campinas 6
Corciano 6
Den Haag 6
Dhaka 6
Duque de Caxias 6
Düsseldorf 6
Guayaquil 6
Lahore 6
Totale 6.893
Salva come PNG Salva come JPEG
Nome #
10-Year Rotavirus Infection Surveillance: Epidemiological Trends in the Pediatric Population of Perugia Province 206
Antibody response and protection after intradermal and intramuscular 2011/2012 trivalent influenza vaccination in elderly volunteers 143
Anti-Biofilm Properties of Saccharomyces cerevisiae CNCM I-3856 and Lacticaseibacillus rhamnosus ATCC 53103 Probiotics against G. vaginalis 139
Antibodies cross-reactive to seasonal influenza A(H1N1)pdm09 viruses in human sera of elderly people immunized with trivalent influenza vaccines containing the A/California/7/09 vaccine strain 133
Accelerate Pheno™ blood culture detection system: a literature review 131
Absence of Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial 126
Antibody Responses after Influenza Vaccination in Elderly People: Useful Information from a 27-Year Study (from 1988–1989 to 2014–2015) 125
Influenza vaccination in patients on long-term anticoagulant therapy. 122
Influenza vaccination in patients on long-term anticoagulant therapy 122
Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial. 119
An influenza A/H3 outbreak during the 2004/2005 winter in elderlyvaccinated people living in a nursing home 118
Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature 118
Molecular analysis of Group of Rotaviruses detected in subjects with severe acute gastroenteritis in Umbria from 2006 to 2012 117
Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59 adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy. 115
Search for SARS-CoV-2 RNA in platelets from COVID-19 patients 115
Annually repeated influenza vaccination and humoral response in elderly volunteers. 114
Effects of probiotic administration on immune responses of children and adolescents with type 1 diabetes to a quadrivalent inactivated influenza vaccine 114
Immunogenicity of the MF-59-adjuvanted influenza vaccine in volunteers of different groups of age. 111
An influenza A/H3 outbreak during the 2004/05 winter in elderly vaccinated people living in a nursing home. 110
A novel methodology based on serological data for improving precision in the influenza vaccine response of non-seroprotected 110
An influenza B outbreak during the 2007/2008 winter among appropriately immunized elderly people living in a nursing home. 108
Antibody response elicited by 2012/2013 “implemented influenza vaccines”, FLUAD® (Novartis Vaccines & Diagnostics) and INTANZA® 15Mcg (Sanofi Pasteur MSD), in chronically ill institutionalized elderly volunteers 108
An observational retrospective study provide information on hospitalization and severe outcomes of the 2009 A(H1N1) infection in Italy. 106
Antibody response against unchanged influenza vaccine components in elderly people vaccinated in consecutive years 106
Influenza vaccine immunogenicity and efficacy in istitutionalized elderly volunteers (winter season 2002/03). 104
Differente risposta anticorpale al vaccine anti-influenzale per l’inverno 2008/2009 in soggetti anziani residenti in due differenti case di riposo. 102
Accuracy and impact on patient management of new tools for diagnosis of sepsis: Experience with the t2 magnetic resonance bacteria panel 102
Antibody responses to intradermal or intramuscular MF59-adjuvanted influenza vaccines as evaluated in elderly institutionalized volunteers during a season of partial mismatching between vaccine and circulatingA(H3N2)strains 101
A G12P[8] rotavirus gastroenteritis outbreak in Italy, 2013 101
Clinical characteristics of influenza A/H1N1, A/H3N2 and B infections in children during three consecutive winter seasons (2012-13, 2013-14 and 2014-15) 101
Induzione di risposta immunitaria e di protezione da parte dei vaccini antinfluenzali in soggetti anziani. 100
Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages 99
An influenza outbreak in elderly vaccinated people in the winter season 2007/2008 99
Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers. 98
Influenza vaccine induced antibody response against B influenza viruses included in the vaccine or naturally circulating during the winter season 2010/2011 97
Comparative study on immunogenicity among split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects 95
Role of nucleocapsid protein antigen detection for safe end of isolation of sars-cov-2 infected patients with long persistence of viral rna in respiratory samples 95
Delivery in asymptomatic Italian woman with SARS-CoV-2 infection 93
Induction of cross-reactive antibodies to 2009 pandemic H1N1 influenza virus (pH1N1) after seasonal vaccination (winters 2003/04 and 2007/08). 92
Drugs for Influenza Treatment: Is There Significant News? 92
Immunogenicity of conventional trivalent inactivated influenza vaccines in pre-vaccination unprotected elderly volunteers in five winters seasons. 91
Comparative study of immunogenicity of split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects 90
The effect of influenza vaccination in patients on long-term oral anticoagulant therapy 88
L’influenza in Umbria nell’inverno 2005/06 88
First detection of a reassortant G3P[8] rotavirus Astrain in Italy: a case report in an 8-year-old child 88
Vaccination against paediatric respiratory pathogens 87
Immunization with adjuvanted and non-adjuvanted influenza vaccines of HIV-1 positive patients treated with highly active antiretroviral therapy (HAART) 86
Multiplex platforms for the identification of respiratory pathogens: Are they useful in pediatric clinical practice? 85
Hospitalization associated with 2009 pandemic influenza A(H1N1) infection in Umbria, a region of central Italy, July – December 2009. 84
MF-59-adjuvanted influenza vaccine: immunogenicity and protection in adult and enderly volunteers (winter season 2003/04). 84
Pandemic Influenza A/H1N1pdm in Italy: Age, Risk and Population Susceptibility 84
UN MAGGIORE UTILIZZO DI SIERI UMANI PUO’ CONTRIBUIRE AD UNA MIGLIORE CARATTERIZZAZIONE ANTIGENICA DEI VIRUS INFLUENZALI PER LA SCELTA DELLE COMPONENTI VACCINALI 84
Influenza vaccine induction of cross–reactive antibodies against different B/Yamagata and B/Victoria-like influenza viruses. , 83
Pro-inflammatory cytokines/ chemokines production after infection of A549 Human epithelial cell line with different strains of human influenza viruses 83
null 83
Co-circulation of SARS-CoV-2 Alpha and Gamma variants in Italy, February and March 2021 83
Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients 83
Group a rotavirus surveillance before vaccine introduction in italy, september 2014 to august 2017 82
The intersubunit region of influenza virus haemagglutinin as a peptide vaccine candidate. 81
Hospital‐acquired rotavirus acute gastroenteritis in 10 consecutive seasons in Umbria (Italy) 81
Cross-reactive antibodies to viruses of both B/Victoria and B/Yamagata lineages as induced by influenza vaccination in middle-aged and elderly volunteers 80
Induction of Cross-Reactive Antibodies to 2009 Pandemic H1N1 Influenza Virus (pH1N1) After Seasonal Vaccination (Winters 2003/04 and 2007/08) 80
Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled, randomized, double-blind crossover study. 80
Monitoring of indoor bioaerosol for the detection of SARS-CoV-2 in different hospital settings 79
Declined antibody response following influenza vaccination in elderly as compared with middle-aged volunteers: effects of aging and/or original antigenic sin? 79
Immunogenicity of the MF-59-adjuvanted vaccine in volunteers of different group of age. 78
Immediate reinfection with Omicron variant after clearance of a previous SARS-CoV-2 infection 76
Detection of Unusual G6 Rotavirus Strains in Italian Children With Diarrhoea During the 2011 Surveillance Season 76
VALUTAZIONE DELL’EFFICACIA PROTETTIVA E DELLA CAPACITA’ DI INDURRE ANTICORPI CROSS-REATTIVI NEI CONFRONTI DI VIRUS INFLUENZALI DI TIPO B APPARTENENTI AI LINEAGGI YAMAGATA E VICTORIA DA PARTE DI DUE VACCINI INFLUENZALI TRIVALENTI (FLUAD® E INTANZA®) IN ANZIANI ISTITUZIONALIZZATI 76
Flow cytometric analysis of intracellular antigen-specific interferon-gamma in human NK and T populations after influenza vaccination 75
Twenty-seven years experience with immunogenicity of inactivated influenza vaccines in the elderly 75
Partial Protection Induced by 2011–2012 Influenza Vaccine Against Serologically Evidenced A(H3N2) Influenza Virus Infections in Elderly Institutionalized People 74
Case report: Coxiella burnetii endocarditis in the absence of evident exposure 73
Induzione di anticorpi omologhi e cross-reattivi nei confronti di virus influenzali di tipo B da parte del vaccino influenzale nell'inverno 2003/2004 73
Design and validation of a self-administered questionnaire to assess knowledge, attitudes and behaviours about Zika virus infection among general population in Italy. A pilot study conducted among Italian residents in public health 73
L'influenza: sistemi di sorveglianza e campagne vaccinali 71
Serological methods are able to determine how well influenza vaccines work 71
Serologically diagnosed influenza virus A/California/7/04 (H3N2)infection in people immunised with A/Fujan/411/2002(H3N2)antigen during the 2004/05 winter season 70
Seroprevalence against pandemic influenza A(H1N1) 2009 after the first season of circulation in Italy 70
Uncommon G9P[4] group A rotavirus strains causing dehydrating diarrhea in young children in Italy 69
Effect of age on serum heterologous antibody response elicited by inactivated influenza virus vaccine 67
Sorveglianza delle paralisi flaccide acute nella regione Umbria 67
Factors influencing humoral immune response after influenza vaccination in elderly and very elderly subjects 67
SARS-CoV-2 in semen: a multicenter prospective study and literature review 66
Increased immunogenicity of an adjuvanted influenza vaccine compared with a conventional subunit vaccine in non-elderly adult HIV seropositive individuals, treated with HAART 66
Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus 66
Co-circulation of the two influenza B lineages during 13 consecutive influenza surveillance seasons in Italy, 2004-2017 66
Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021 65
Vaccinazione antinfluenzale in soggetti HIV-1 positivi trattati con HAART: influenza sulla risposta anticorpale della concentrazione plasmatici di HIV-1 RNA e del numero di CD4+ 65
Inhibitor development in mild/moderate haemophilia: could influenza vaccination have been the trigger? 65
Sorveglianza molecolare delle gastroenteriti da rotavirus in Umbria 65
Unexpected spreading of G12P[8] rotavirus strains among young children in a small area of central Italy 64
Measles immunity in healthcare workers of an Italian hospital 64
Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022 64
Hospital discharges-based search of acute flaccid paralysis cases 2007-2016 in Italy and comparison with the National Surveillance System for monitoring the risk of polio reintroduction 63
SARS-CoV-2 Molecular Evolution: A Focus on Omicron Variants in Umbria, Italy 63
Immunogenicity of the MF-59-adjuvanted influenza vaccine in volunteers of different groups of age 63
Efficacy of an inactivated influenza vaccine among well immunized nursing home residents during the 2007/2008 season 63
Immunogenicità ed efficacia protettiva del vaccino influenzale per l’inverno 2007/08 in soggetti residenti in casa di riposo 63
Intradermal and intramuscular 2011-2012 influenza vaccination of elderly institutionalized volunteers: induction of antibody responses against vaccine and epidemic influenza virus strains 63
Totale 8.998
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.113
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.113
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021392 0 0 0 0 0 0 0 0 0 18 70 304
2021/2022825 17 152 6 21 31 16 7 308 15 14 103 135
2022/20231.622 119 176 14 144 125 181 3 83 694 5 54 24
2023/2024766 70 67 40 15 7 4 183 33 114 20 121 92
2024/20251.964 25 195 58 87 308 91 97 86 361 142 317 197
2025/20263.850 258 256 217 509 531 382 710 219 466 302 0 0
Totale 10.909